Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Enovix

Hidden Gems: 2 Small-Cap Tech Stocks Poised for Growth

Wall Street believes these under-the-radar companies will soar in the coming years.

Is Enovix a Small-Cap Battery Stock Worth Buying?

Is Enovix a Small-Cap Battery Stock Worth Buying?

Enovix Corp. (ENVX), the next-generation battery maker, has generated far more hype than demonstrated results. While the several promising updates position the company at an inflection point, let’s find out if ENVX is worth buying. Read on….

Enovix Stock Scores RS Rating Upgrade To 97

Enovix Stock Scores RS Rating Upgrade To 97

Enovix sees its Relative Strength Rating reach the elite 90-plus level.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Enovix Clears Technical Benchmark, Hitting 80-Plus RS Rating

Enovix sees its Relative Strength Rating enter the 80-plus level.

Investors Business Daily

Battery Startup Soars As Smartphone Customers Line Up

Enovix stock rocketed as the startup company prepares to ramp production of its advanced batteries for smartphone customers.

Investors Business Daily

Enovix Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating

Enovix shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 84.

Investors Business Daily

Enovix Stock Scores Rising Relative Strength Upgrade

A Relative Strength Rating upgrade for Enovix shows improving technical performance.

Investors Business Daily

inkl

Read news from The Economist, FT, and more,
with one subscription

Enovix Stock Today: Why A Diagonal Calendar Spread In Options Trading Could Make Infinite Gains

Enovix Stock Today: Why A Diagonal Calendar Spread In Options Trading Could Make Infinite Gains

The risk of $1.80 per set of contracts sets the maximum loss and remains fixed.

Investors Business Daily

Enovix Stock Shows Rising Relative Strength, Hitting 80+

Enovix Stock Shows Rising Relative Strength, Hitting 80+

Enovix shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 73 to 85.

Investors Business Daily

Enovix Stock Sees Another Relative Strength Rating Jump To 93

Enovix Stock Sees Another Relative Strength Rating Jump To 93

Enovix sees its Relative Strength Rating enter the elite 90-plus level.

Investors Business Daily

Enovix Stock Shows Market Leadership, Earns 95 RS Rating

Enovix Stock Shows Market Leadership, Earns 95 RS Rating

Enovix sees its Relative Strength Rating move into the elite 90-plus level.

Investors Business Daily

Battery Maker Enovix Hopes To Recharge With New CEO, Strategy

Battery Maker Enovix Hopes To Recharge With New CEO, Strategy

Enovix stock has been on a roller-coaster ride since the battery maker went public less than two years ago.

Investors Business Daily

Check Out What Whales Are Doing With ENVX

Check Out What Whales Are Doing With ENVX

Someone with a lot of money to spend has taken a bearish stance on Enovix (NASDAQ:ENVX). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2022

Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2022

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Enovix Stock Rockets As Next-Generation Battery Maker Hits Big Milestones

Enovix shares rocketed Thursday after the maker of next-generation lithium-ion batteries announced several big milestones.

11 Industrials Stocks Moving In Thursday's Intraday Session

Why Are Enovix Shares Trading Lower Today

Cowen analyst Gabe Daoud lowered the price target on Enovix Corp (NASDAQ:ENVX) to $29 from $32 and maintained an Outperform rating on the shares. Daoud notes its revenue funnel grew as management highlighted significant demand/interest with applications emerging across doorbells, GPS, and medical devices. Craig-Hallum analyst Anthony Stoss lowered the price target to $35 (171% upside)…

1

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Gilead Sciences

Edwards Lifesciences

L3Harris Technologies

Stanley Black Decker

Core Scientific

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play